Kittisak Kaewchalun Novavax (NASDAQ:NVAX) has received marketing authorization from the European Commission for its updated
greenleaf123/iStock via Getty Images Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) on Tuesday successfully convinced London’s High
CatEyePerspective The Committee for Medicinal Products for Human Use (OTC:CHMP) of the European Medicines Agency
Sean Gallup BioNTech (NASDAQ:BNTX) shares traded higher on Tuesday after Jefferies upgraded the German COVID-19
koto_feja After Summit Therapeutics (NASDAQ:SMMT) said early this week that its lead asset ivonescimab outperformed
Summary: BioNTech shares surged 13% after Summit Therapeutics reported positive data on ivonescimab, a bispecific
Tempus AI (NASDAQ:TEM) announced a multi-year collaboration with BioNTech SE (NASDAQ:BNTX) which leverages Tempus’ multimodal
Amornrat Phuchom/iStock via Getty Images A new formulation of COVID-19 shots from Moderna (NASDAQ:MRNA) and
Summary: Partial clinical hold of BioNTech SE’s BNT326/YL202 for the treatment of patients with solid
Sean Gallup The U.S. FDA has lifted a partial clinical hold on a phase 1